Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion type Assertion NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_head.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion evidence source_evidence_literature NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion SIO_000772 19015641 NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion wasDerivedFrom befree-2016 NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion wasGeneratedBy ECO_0000203 NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.